This article was written by Maya Horgan Famodu – partner & founder of Ingressive Capital – and reviewed by TechCabal’s editorial team. All views are hers and not attributable to TechCabal. Sustainability and African tech startups Ingressive Capital is soon launching our second Africa-focused investment fund at a much larger size, and for those of…

Last week US regulators recommended resuming use of the Johnson & Johnson vaccine, after deciding that a side effect involving blood clots was too rare to justify continuing the brief suspension they had imposed: there were just 15 reported instances out of 8 million doses. But even though the pause lasted just 11 days, it…